Case Studies

Philippines, July 2016 – Ex-health secretary indicted for graft

Visit Case Study

Pakistan, September 2016 – Embezzlement of millions of rupees while procuring medical supplies

Visit Case Study

USA, July 2016 – Outrage of the Month: Doctors Accepting Bribes, Betraying Patients

Visit Case Study

USA, August 2016 – Whistleblower collects $3.5 million from Johnson & Johnson unit

Visit Case Study

Romania, May 2016 – Boss at heart of Romanian scandal over diluted disinfectant dies in car crash

Visit Case Study

In the USA, the effects of undue lobbying and its impact on health have drawn attention. Evidence suggests that the pharmaceutical industry is the largest lobbying group, with spending in 2015 totaling US$240 million,[1] allowing the industry to successfully influence US health policy that may compromise public health objectives. For example, revisions in 2003 to…

Read Case Study »

The Pharmaceuticals & Healthcare Programme is an international programme of Transparency International, based in the London office of Transparency International UK.

Contact Us